Artwork

Content provided by Dr. Michael Hyland, DPT, CEEAA, Dr. Michael Hyland, DPT, and CEEAA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Michael Hyland, DPT, CEEAA, Dr. Michael Hyland, DPT, and CEEAA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

A Shocking New Treatment for Parkinson’s: How LESS Dopamine Could Halt Progression

16:58
 
Share
 

Manage episode 470990895 series 3559715
Content provided by Dr. Michael Hyland, DPT, CEEAA, Dr. Michael Hyland, DPT, and CEEAA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Michael Hyland, DPT, CEEAA, Dr. Michael Hyland, DPT, and CEEAA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Could a simple drug intended to treat cancer treatment complications be the next big breakthrough in Parkinson’s Disease treatment? Dr. Jonathan Sackner-Bernstein, MD, is leading research on tyrosine hydroxylase inhibition as a novel approach to managing Parkinson’s symptoms and slowing disease progression. Unlike traditional treatments that focus solely on replacing lost dopamine, a previously FDA approved drug (RB-190) targets tyrosine hydroxylase (TH)—the enzyme responsible for dopamine production—offering a new way to reduce dyskinesias, oxidative stress, and dopamine imbalances in the brain. Watch on YouTube

In this episode, we’ll break down:

✅ What tyrosine hydroxylase does and its role in dopamine production

✅ Why too much dopamine in certain brain regions can be problematic

✅ How RB-190 could change the way we treat Parkinson’s Disease

✅ The groundbreaking work of Dr. Sackner-Bernstein and what it means for the future

If you or a loved one is affected by Parkinson’s, this research could be a game-changer! Stay informed about the latest treatments and breakthroughs by liking, subscribing, and turning on notifications. You all will be the FIRST to know when phase IIA of the drug trials start and participants are needed. Follow Dr. Bernstein's blog here: https://www.parkinsonsdisease.blog/

🔔 Subscribe/follow for more Parkinson’s insights! 📢 Let us know in the comments—what do you think of this potential treatment?

Help to support this channel and out efforts to educate the world about Parkinson's Disease and get access to personalized content: https://www.youtube.com/channel/UC0g3abv8hkaqZbGD8y1dfYQ/join

https://www.patreon.com/pdeducation

Please be sure to give support to our channel sponsors:

Comfort Linen: https://comfortlinen.com/PARKINSONSDISEASEEDUCATION (15% off entire order when applying the code PARKINSONSDISEASEEDUCATION at checkout)

Kizik Shoes: https://kizik.sjv.io/pdeducation

Cure Hydration: https://lvnta.com/lv_XG06Rho8SSlXEq3qlV

If you have products that you would like for me to review on the channel please send them here:

Parkinson's Disease Education

P.O. Box 1678

Broken Arrow, OK 74013

Medical Disclaimer: All information, content, and material of this video is for informational purposes only and not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.

Affiliate disclaimer: Keep in mind that links used for recommended products may earn me a commission when you make purchases. However, this does not impact what products I recommend. If I recommend a specific product it is because it has been vetted by myself or based on personal use

#parkinson #parkinsonsawareness #parkinsonsdisease #parkinsons #ParkinsonsDisease #Dopamine #TyrosineHydroxylase #JonathanSacknerBernstein #Neuroscience #MedicalBreakthrough

  continue reading

114 episodes

Artwork
iconShare
 
Manage episode 470990895 series 3559715
Content provided by Dr. Michael Hyland, DPT, CEEAA, Dr. Michael Hyland, DPT, and CEEAA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Michael Hyland, DPT, CEEAA, Dr. Michael Hyland, DPT, and CEEAA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Could a simple drug intended to treat cancer treatment complications be the next big breakthrough in Parkinson’s Disease treatment? Dr. Jonathan Sackner-Bernstein, MD, is leading research on tyrosine hydroxylase inhibition as a novel approach to managing Parkinson’s symptoms and slowing disease progression. Unlike traditional treatments that focus solely on replacing lost dopamine, a previously FDA approved drug (RB-190) targets tyrosine hydroxylase (TH)—the enzyme responsible for dopamine production—offering a new way to reduce dyskinesias, oxidative stress, and dopamine imbalances in the brain. Watch on YouTube

In this episode, we’ll break down:

✅ What tyrosine hydroxylase does and its role in dopamine production

✅ Why too much dopamine in certain brain regions can be problematic

✅ How RB-190 could change the way we treat Parkinson’s Disease

✅ The groundbreaking work of Dr. Sackner-Bernstein and what it means for the future

If you or a loved one is affected by Parkinson’s, this research could be a game-changer! Stay informed about the latest treatments and breakthroughs by liking, subscribing, and turning on notifications. You all will be the FIRST to know when phase IIA of the drug trials start and participants are needed. Follow Dr. Bernstein's blog here: https://www.parkinsonsdisease.blog/

🔔 Subscribe/follow for more Parkinson’s insights! 📢 Let us know in the comments—what do you think of this potential treatment?

Help to support this channel and out efforts to educate the world about Parkinson's Disease and get access to personalized content: https://www.youtube.com/channel/UC0g3abv8hkaqZbGD8y1dfYQ/join

https://www.patreon.com/pdeducation

Please be sure to give support to our channel sponsors:

Comfort Linen: https://comfortlinen.com/PARKINSONSDISEASEEDUCATION (15% off entire order when applying the code PARKINSONSDISEASEEDUCATION at checkout)

Kizik Shoes: https://kizik.sjv.io/pdeducation

Cure Hydration: https://lvnta.com/lv_XG06Rho8SSlXEq3qlV

If you have products that you would like for me to review on the channel please send them here:

Parkinson's Disease Education

P.O. Box 1678

Broken Arrow, OK 74013

Medical Disclaimer: All information, content, and material of this video is for informational purposes only and not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.

Affiliate disclaimer: Keep in mind that links used for recommended products may earn me a commission when you make purchases. However, this does not impact what products I recommend. If I recommend a specific product it is because it has been vetted by myself or based on personal use

#parkinson #parkinsonsawareness #parkinsonsdisease #parkinsons #ParkinsonsDisease #Dopamine #TyrosineHydroxylase #JonathanSacknerBernstein #Neuroscience #MedicalBreakthrough

  continue reading

114 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play